1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Covalent Functionalization of Bioengineered Polyhydroxyalkanoate Spheres Directed by Specific Protein-Protein Interactions

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Bioengineered polyhydroxyalkanoate (PHA) spheres assembled in engineered bacteria are showing promising potential in protein immobilization for high-value applications. Here, we have designed innovative streamlined approaches to add functional proteins from complex mixtures (e.g., without prior purification) to bioengineered PHA spheres directly harnessing the specificity of the SpyTag/SpyCatcher mediated protein ligation. Escherichia coli was engineered to assemble PHA spheres displaying the SpyCatcher domain while simultaneously producing a SpyTagged target protein, which was in vivo specifically ligated to the PHA spheres. To further demonstrate the specificity of this ligation reaction, we incubated isolated SpyCatcher-coated PHA spheres with cell lysates containing SpyTagged target protein, which also resulted in specific ligation mediating surface functionalization. An even cruder approach was used by lysing a mixture of cells, either producing PHA spheres or target protein, which resulted in specific surface functionalization suggesting that ligation between the SpyCatcher-coated PHA spheres and the SpyTagged target proteins is highly specific. To expand the design space of this general modular approach toward programmable multifunctionalization, e.g., one-pot construction of immobilized multienzyme cascade systems on PHA spheres, we designed various recombinant bimodular PHA spheres utilizing alternative Tag/Catcher pairs (e.g., SnoopTag/SnoopCatcher and SdyTag/SdyCatcher systems). One of our bimodular PHA spheres resulted in simultaneous multifunctionalization of plain PHA spheres in one-step with two differently tagged proteins under in vitro and ex vivo reaction conditions while remaining functional. Our bimodular PHA spheres also showed high orthogonality with the non-target peptide tag and exhibited decent robustness against repeated freeze-thaw treatment. We demonstrated the utility of these approaches by using a fluorescent protein, a monomeric amylase, and a dimeric organophosphate hydrolase as target proteins. We established a versatile toolbox for dynamic functionalization of PHA spheres for biomedical and industrial applications.

          Related collections

          Most cited references47

          • Record: found
          • Abstract: not found
          • Book Chapter: not found

          Protein Identification and Analysis Tools on the ExPASy Server

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Challenges in Development of Nanoparticle-Based Therapeutics

            Neil Desai (2012)
            In recent years, nanotechnology has been increasingly applied to the area of drug development. Nanoparticle-based therapeutics can confer the ability to overcome biological barriers, effectively deliver hydrophobic drugs and biologics, and preferentially target sites of disease. However, despite these potential advantages, only a relatively small number of nanoparticle-based medicines have been approved for clinical use, with numerous challenges and hurdles at different stages of development. The complexity of nanoparticles as multi-component three dimensional constructs requires careful design and engineering, detailed orthogonal analysis methods, and reproducible scale-up and manufacturing process to achieve a consistent product with the intended physicochemical characteristics, biological behaviors, and pharmacological profiles. The safety and efficacy of nanomedicines can be influenced by minor variations in multiple parameters and need to be carefully examined in preclinical and clinical studies, particularly in context of the biodistribution, targeting to intended sites, and potential immune toxicities. Overall, nanomedicines may present additional development and regulatory considerations compared with conventional medicines, and while there is generally a lack of regulatory standards in the examination of nanoparticle-based medicines as a unique category of therapeutic agents, efforts are being made in this direction. This review summarizes challenges likely to be encountered during the development and approval of nanoparticle-based therapeutics, and discusses potential strategies for drug developers and regulatory agencies to accelerate the growth of this important field.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Recent progress in multienzymes co-immobilization and multienzyme system applications

                Bookmark

                Author and article information

                Contributors
                Journal
                Front Bioeng Biotechnol
                Front Bioeng Biotechnol
                Front. Bioeng. Biotechnol.
                Frontiers in Bioengineering and Biotechnology
                Frontiers Media S.A.
                2296-4185
                06 February 2020
                2020
                : 8
                : 44
                Affiliations
                [1] 1School of Fundamental Sciences, Massey University , Palmerston North, New Zealand
                [2] 2MacDiarmid Institute for Advanced Materials and Nanotechnology, Victoria University of Wellington , Wellington, New Zealand
                [3] 3Adaptive Immunity, Biomedical Centre, Lund University , Lund, Sweden
                [4] 4Centre for Cell Factories and Biopolymers, Griffith Institute for Drug Discovery, Griffith University , Nathan, QLD, Australia
                Author notes

                Edited by: Ken’ichiro Matsumoto, Hokkaido University, Japan

                Reviewed by: Christopher Nomura, SUNY College of Environmental Science and Forestry, United States; Tsutomu Tanaka, Kobe University, Japan

                *Correspondence: Bernd H. A. Rehm, b.rehm@ 123456griffith.edu.au

                This article was submitted to Biomaterials, a section of the journal Frontiers in Bioengineering and Biotechnology

                Article
                10.3389/fbioe.2020.00044
                7015861
                32117925
                50270995-349c-4c94-9bf4-ab19933dfab4
                Copyright © 2020 Wong, Gonzalez-Miro, Sutherland-Smith and Rehm.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 25 November 2019
                : 21 January 2020
                Page count
                Figures: 10, Tables: 0, Equations: 0, References: 56, Pages: 19, Words: 0
                Categories
                Bioengineering and Biotechnology
                Original Research

                polyhydroxyalkanoates,polyesters,tag/catcher systems,modular functionalization,synthetic biology,biotechnology,polymer science

                Comments

                Comment on this article